Simultaneous pHototherapeutic Keratectomy and corneAl Collagen cRosslinking in Eyes With Keratoconus: a Randomized Trial (SHARK)

Recruiting now · Not applicable

Conditions studied: Keratoconus

In brief

The goal of this clinical trial is to compare CXL with combined treatment with CXL and t-PTK. The main questions it aims to answer are whether combined treatment can give better visual acuity and if the treatments are equally safe.

Key facts

Study ID

NCT06264024

Run by

Oslo University Hospital

People needed

81

Starts

2024-02-12

Expected to finish

2034-02-01

Last updated by the study team

2024-02-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients must be 18 years or older at the time of signing the informed consent form. There is no upper age limit.
• Progressive keratoconus with indication for CXL
• Corneal thickness ≥ 420 μm

You may not qualify if…

• Other eye disease causing visual impairment

Where it is running

• Department of Ophhtalmology, University of Oslo — Oslo, Norway (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.